Alefacept in the treatment of psoriatic nail disease: a proof of concept study.

Academic Article

Abstract

  • Nail psoriasis can be debilitating and as therapeutic options are limited, it can be notoriously difficult to treat. As there are many new medications currently undergoing clinical trials in psoriasis, questions have arisen concerning the effectiveness of these new therapies with regard to psoriatic nail disease. We present the results of a prospective, open-label, proof of concept study to determine the efficacy and safety of alefacept in subjects with moderate to severe nail psoriasis.
  • Published In

    Keywords

  • Adult, Alefacept, Drug Administration Schedule, Humans, Immunosuppressive Agents, Middle Aged, Nail Diseases, Prognosis, Psoriasis, Recombinant Fusion Proteins, Severity of Illness Index, Time Factors, Treatment Outcome
  • Authorlist

  • Parrish CA; Sobera JO; Robbins CM; Cantrell WC; Desmond RA; Elewski BE
  • Start Page

  • 339
  • End Page

  • 340
  • Volume

  • 5
  • Issue

  • 4